Seeing Is Believing
KYTX is currently covered by 4 analysts with an average price target of $31. This is a potential upside of $25.33 (446.74%) from yesterday's end of day stock price of $5.67.
Kyverna Therapeutics's activity chart (see below) currently has 23 price targets and 22 ratings on display. The stock rating distribution of KYTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 21.15% with an average time for these price targets to be met of 22.88 days.
Highest price target for KYTX is $33, Lowest price target is $25, average price target is $31.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 03-Jun-2026. First documented stock forecast 04-Mar-2024.
Currently out of the existing stock ratings of KYTX, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Aug-2025
$25
$19.33 (340.92%)
$25
4 months 29 days ago
(03-Jun-2026)
9/13 (69.23%)
$17.18 (219.69%)
92
Buy Since 04-Mar-2024
$29
$23.33 (411.46%)
$33
5 months 19 days ago
(13-May-2026)
0/3 (0%)
$18.22 (169.02%)
Buy Since 08-Oct-2025
$33
$27.33 (482.01%)
$31
10 months 16 days ago
(16-Dec-2025)
0/3 (0%)
$22.76 (222.27%)
Buy Since 04-Mar-2024
$33
$27.33 (482.01%)
10 months 17 days ago
(15-Dec-2025)
0/2 (0%)
$22.18 (204.99%)
What is KYTX (Kyverna Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KYTX (Kyverna Therapeutics)?
Which analyst has the most public recommendations on KYTX (Kyverna Therapeutics)?
Which analyst is the currently most bullish on KYTX (Kyverna Therapeutics)?
Which analyst is the currently most reserved on KYTX (Kyverna Therapeutics)?